期刊
FUTURE MICROBIOLOGY
卷 2, 期 6, 页码 655-666出版社
FUTURE MEDICINE LTD
DOI: 10.2217/17460913.2.6.655
关键词
antibiotic resistance; Grain-positive pathogens; immunotherapy; MRSA; new targets; novel antibacrerials; Stapbylococcus aureus
类别
Multiple resistant staphylococci that cause significant morbidity and mortality are the leading cause of nosocomial infections. Meanwhile, methicillin-resistant Staphylococcus aureus (MRSA) also spreads in the community, where highly virulent strains infect children and young adults who have no predisposing risk factors. Although some treatment options remain, the search for new antibacterial targets and lead compounds is urgently required to ensure that staphylococcal infections can be effectively treated in the future. Promising targets for new antibacterials are gene products that are involved in essential cell functions. In addition to antibacterials, active and passive immunization strategies are being developed that target surface components of staphylococci such as cell wall-linked adhesins, teichoic acids and capsule or immunodominant antigens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据